Finland· FI-REL-REL43687
MILPRO VET
A milbemycin oxime, combinations product containing milbemycin oxime + praziquantel, registered in Finland by Virbac. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Milbemycin oxime + praziquantel is registered in 2 of 19 countries.
Countries holding a registration under ATC QP54AB51 (milbemycin oxime, combinations), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 1 of them publish a price we can compare per daily dose
Milbemycin oxime + praziquantel · ATC QP54AB51
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Milbemycin oxime + Praziquantel
- Manufacturer
- Virbac
- Country
- Finland (FI)
- ATC code
- QP54AB51
- ATC class
- milbemycin oxime, combinations
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Milbemycin oxime + praziquantel in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ecdcb366-7850-406b-810c-789c9694adb4 GET /v1/drugs/ecdcb366-7850-406b-810c-789c9694adb4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": null,
"strength": "12.5 mg / 125 mg",
"atc_label": "milbemycin oxime, combinations",
"ma_number": "31557",
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": null,
"fimea_rel_id": "REL43687",
"authorised_at": "2015-08-26"
}See everything about milbemycin oxime + praziquantel.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.